BioGend Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	217.9	219.02	330.51	163.64	136.32
Short-Term Investments	300	400	393.76	329.76	552.96
Cash & Short-Term Investments	517.9	619.02	724.27	493.4	689.28
Cash Growth	-16.34%	-14.53%	46.79%	-28.42%	34.36%
Accounts Receivable	58.96	47.36	26.69	11.27	5.05
Other Receivables	2.61	33.37	30.67	28.25	23.61
Receivables	61.56	80.72	57.36	39.52	28.66
Inventory	20.52	15.96	16.55	4.9	9.03
Prepaid Expenses	36.45	2	3	4.07	7.57
Total Current Assets	636.43	717.7	801.18	541.89	734.54
Property, Plant & Equipment	43.11	49.57	56.2	34.01	8.89
Long-Term Investments	7.65	8.33	20.34	10	-
Goodwill	-	17.09	17.09	17.09	17.09
Other Intangible Assets	90.34	114.07	151.04	210.95	261.92
Other Long-Term Assets	37.85	5.94	4.64	7.89	1.42
Total Assets	815.38	912.7	1,050	821.82	1,024
Accounts Payable	2.09	4.22	2.16	2.08	0.49
Accrued Expenses	-	20.61	16.57	17.22	14.39
Current Portion of Leases	3.73	3.59	3.65	3.49	3.94
Other Current Liabilities	30.35	4.81	23.87	9.07	6.3
Total Current Liabilities	36.16	33.23	46.25	31.86	25.13
Long-Term Leases	2.85	5.84	9.44	12.28	0.48
Long-Term Unearned Revenue	-	-	2.5	2.5	2.5
Long-Term Deferred Tax Liabilities	18.73	27.13	35.52	43.92	52.31
Total Liabilities	57.74	66.19	93.71	90.56	80.42
Common Stock	1,244	1,243	1,231	1,031	1,031
Additional Paid-In Capital	-	-	-	-	212.85
Retained Earnings	-482.93	-398.32	-281.85	-325.52	-353.91
Comprehensive Income & Other	-18.54	-26.58	-7.96	-2.38	-2.16
Total Common Equity	742.09	817.67	940.96	702.86	887.54
Minority Interest	15.55	28.84	15.81	28.4	55.91
Shareholders' Equity	757.64	846.51	956.77	731.27	943.45
Total Liabilities & Equity	815.38	912.7	1,050	821.82	1,024
Total Debt	6.58	9.43	13.09	15.77	4.42
Net Cash (Debt)	511.33	609.59	711.18	477.64	684.86
Net Cash Growth	-16.12%	-14.28%	48.90%	-30.26%	33.49%
Net Cash Per Share	4.17	4.95	5.91	4.63	6.76
Filing Date Shares Outstanding	121.26	124.26	123.08	103.08	103.08
Total Common Shares Outstanding	121.26	124.26	123.08	103.08	103.08
Working Capital	600.27	684.47	754.93	510.03	709.42
Book Value Per Share	6.12	6.58	7.65	6.82	8.61
Tangible Book Value	651.75	686.51	772.83	474.82	608.52
Tangible Book Value Per Share	5.37	5.52	6.28	4.61	5.90
Machinery	-	31.6	31.19	24.66	24.55
Construction In Progress	-	-	37.57	14.91	-
Leasehold Improvements	-	38.15	0.34	0.34	0.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.